{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:14:57Z","timestamp":1778217297495,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"abstract":"<jats:p>The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and benign prostatic hyperplasia (BPH) is controversial and has rarely been studied in the U.S. population. This study utilized data from 4 cycles of the National Health and Nutrition Examination Survey conducted between 2001 and 2008, and the diagnosis of BPH relied primarily on self-reporting by participants. In order to deeply analyze the association between the NHHR and BPH, the study adopted a variety of statistical tools including multivariate logistic regression, smoothed curve fitting, and subgroup analysis. Together, these methods were designed to reveal potential associations between the 2 . A total of 5687 participants were enrolled in this study, including 873 BPH participants and 4814 controls. The NHHR was generally lower in the BPH group than in the control group. After fully adjusting for all confounders, the risk of developing BPH was reduced by 8% (95% CI = 0.85\u20130.96, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002) for each unit increase in NHHR. Compared with the first quartile of NHHR, those in the fourth quartile of NHHR were 24% less likely to develop BPH (95% CI = 0.60\u20130.96, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.024). Subgroup analyses found that NHHR was negatively associated with BPH in those aged 60 years or older, those who were married or living with a partner, those with a college degree or higher, former smokers, nondrinkers, and those with a BMI\u2005&lt;\u200525. NHHR may have a potential protective effect on BPH. However, its exact biological mechanism remains to be elucidated by further scientific studies.<\/jats:p>","DOI":"10.1097\/md.0000000000042840","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:01:25Z","timestamp":1750215685000},"page":"e42840","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in relation to benign prostatic hyperplasia: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhimin","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Urology, Handan First Hospital, Handan, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Urology, Handan First Hospital, Handan, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Handan First Hospital, Handan, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, Handan First Hospital, Handan, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3024-1061","authenticated-orcid":false,"given":"Mingtao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Handan First Hospital, Handan, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia \u2013 what do we know?","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/tau.2019.10.01","article-title":"Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.","volume":"8","author":"Lokeshwar","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","article-title":"Benign prostatic hyperplasia.","volume":"2","author":"Chughtai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0045(19970501)31:2<131::AID-PROS9>3.0.CO;2-Q","article-title":"Intrinsic and extrinsic factors controlling benign prostatic growth.","volume":"31","author":"Lee","year":"1997","journal-title":"Prostate"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrurol.2015.301","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.","volume":"13","author":"Vignozzi","year":"2016","journal-title":"Nat Rev Urol"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"999995","DOI":"10.3389\/fnut.2022.999995","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Nutr"},{"key":"R7-20250618","first-page":"CD007957","article-title":"Low-fat diets for acquired hypercholesterolaemia.","volume":"2011","author":"Smart","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"e17635","DOI":"10.1097\/MD.0000000000017635","article-title":"Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.","volume":"98","author":"Park","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.2147\/DMSO.S414673","article-title":"The relationship between non-HDL-C\/HDL-C ratio (NHHR) and vitamin D in type 2 diabetes mellitus.","volume":"16","author":"Zhen","year":"2023","journal-title":"Diab Metab Syndrome Obesity"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.numecd.2015.03.003","article-title":"Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.","volume":"25","author":"Zuo","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12944-024-02089-x","article-title":"The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stones: a cross-sectional study.","volume":"23","author":"Hong","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"804457","DOI":"10.3389\/fendo.2021.804457","article-title":"Exposure to Di-2-ethylhexyl phthalate and benign prostatic hyperplasia, NHANES 2001-2008.","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"875134","DOI":"10.3389\/fneur.2022.875134","article-title":"Non-HDL-C\/HDL-C ratio is associated with carotid plaque stability in general population: a cross-sectional study.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Neurol"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-063014-123902","article-title":"Management of benign prostatic hyperplasia.","volume":"67","author":"Kim","year":"2016","journal-title":"Annu Rev Med"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1038\/s41598-017-06628-8","article-title":"The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis.","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"1557988319870382","DOI":"10.1177\/1557988319870382","article-title":"Body mass index and risk of prostate volume, international prostate symptom score, maximum urinary flow rate, and post-void residual in benign prostatic hyperplasia patients.","volume":"13","author":"Li","year":"2019","journal-title":"Am J Men\u2019s Health"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.juro.2013.08.110","article-title":"A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.","volume":"191","author":"Mondul","year":"2014","journal-title":"J Urol"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00345-018-2568-0","article-title":"The effect of diet on BPH, LUTS and ED.","volume":"37","author":"ElJalby","year":"2019","journal-title":"World J Urol"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12967-022-03722-y","article-title":"Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/DMSO.S355980","article-title":"Utility of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk.","volume":"15","author":"Sheng","year":"2022","journal-title":"Diab Metab Syndrome Obesity"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.ijcard.2013.03.027","article-title":"Non-HDL-cholesterol\/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B\/apolipoprotein A1.","volume":"168","author":"Kim","year":"2013","journal-title":"Int J Cardiol"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/pros.22623","article-title":"Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.","volume":"73","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bju.12728","article-title":"Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.","volume":"115","author":"Gacci","year":"2015","journal-title":"BJU Int"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2006.01.019","article-title":"Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.","volume":"370","author":"Nandeesha","year":"2006","journal-title":"Clin Chim Acta"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:01:29Z","timestamp":1750215689000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":24,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042840","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}